FIELD: medicine, cardiology. SUBSTANCE: agent has, wt.-%: nitroglycerol 1.0-1.5; water-soluble agent for resorption acceleration 15-25; analgin 2-3; potassium chloride 0.4-0.5; magnesium sulfate 1.0-1.2; adenosine triphosphoric acid 0.3-0.5; creatine phosphate 0.2-0.6; prednisolone 0.02-0.04; novocaine 0.1-0.2; ethanol 30-40, and water - the rest. Agent is used for stopping and prophylaxis of stenocardia attack, in ischemic heart disease therapy. EFFECT: enhanced effectiveness, nontoxic property, absence of complications and by-side effects, simplified preparing. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ISCHEMIA | 1990 |
|
RU2012376C1 |
ELECTRIC DISCHARGER | 1990 |
|
RU2012375C1 |
METHOD OF TREATMENT OF CARDIAC RHYTHM DISTURBANCES | 0 |
|
SU1438789A1 |
METHOD OF STENOCARDIA TREATMENT | 2008 |
|
RU2376972C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF ANGINA PECTORIS CASES | 2003 |
|
RU2256398C2 |
METHOD FOR TREATING THE CASES OF CARDIAC ISCHEMIA DISEASE | 2000 |
|
RU2174023C1 |
METHOD TO TREAT STENOCARDIA SYNDROME AT ISCHEMIC CARDIAC DISEASE | 1993 |
|
RU2082414C1 |
ANTIANGINAL AGENT | 2001 |
|
RU2200026C2 |
METHOD OF NONSTABLE STENOCARDIA TREATMENT | 1992 |
|
RU2072842C1 |
AGENT FOR TREATMENT OF PATIENTS WITH NONSTABLE STENOCARDIA AND ACUTE MYOCARDIAL INFARCTION | 2000 |
|
RU2168993C1 |
Authors
Dates
1996-08-10—Published
1992-03-02—Filed